At PromiseCare Medical Group in Hemet, California, patients facing the challenges of brain and spine abnormalities can find hope in stereotactic radiosurgery (SRS), a non-invasive radiation therapy that precisely targets tumors and lesions while minimizing damage to surrounding healthy tissue.
Using SRS, patients enjoy lower surgical risks and quicker recovery periods than with conventional surgery. This groundbreaking procedure has been effective for benign and malignant tumors, arteriovenous malformations, and metastatic lesions.
When patients consider SRS, they may have questions about what lies ahead—from preparation and the procedure itself to immediate results and long-term impacts. Understanding the treatment process is crucial for allowing patients to make knowledgeable decisions about their care.
Overview
Stereotactic radiosurgery (SRS) is a non-invasive radiation treatment that employs a focused and powerful beam of light to target irregularities in the brain and spine. It administers high radiation doses directly to tumors, reducing harm to adjacent healthy tissue.
During the procedure, multiple focused radiation beams converge on the targeted area, releasing a precise dose that spares delicate brain tissue.
SRS offers reduced surgical risks and shorter recovery times, as it doesn’t require incisions or general anesthesia. Side effects may arise, but are generally milder than those associated with conventional radiotherapy. Temporary fatigue and localized skin irritation are the most common symptoms.
This treatment is effective for various conditions, including benign and malignant brain tumors, arteriovenous malformations, and metastatic tumors. By utilizing advanced 3D imaging and precise radiation delivery, SRS provides a treatment option with minimal collateral damage.
Types
Stereotactic radiosurgery encompasses various technologies, each with unique strengths and applications. The specifics of the condition are considered when choosing the most suitable option.
Technologies Used in Stereotactic Radiosurgery
- Gamma Knife: Employs focused gamma rays to precisely treat minor to medium-sized brain lesions.
- Linear Accelerator (LINAC): This device delivers high-energy X-rays to treat brain and body tumors, often requiring multiple sessions for larger lesions.
- Proton Beam Therapy is an emerging method that uses protons instead of X-rays. It allows for targeted radiation with minimal damage to healthy surrounding tissues.
- Stereotactic Body Radiotherapy (SBRT) / Stereotactic Ablative Radiotherapy (SABR): This treatment method applies SRS principles to treat body tumors in one to five sessions, effectively targeting challenging tumors near essential organs with high doses of radiation.
Each technology offers distinct advantages in treating brain tumors and lesions. Understanding these options enables better discussion of the best course of treatment.
Stereotactic radiosurgery aims to deliver precise, high doses of radiation while preserving the integrity of surrounding tissues.
Why it’s done
Stereotactic radiosurgery (SRS) is a precision-driven treatment that targets brain and spine abnormalities while safeguarding surrounding healthy tissue. It is particularly effective in tackling intricate, benign, or malignant brain tumors with unprecedented accuracy.
As a minimally invasive procedure, SRS is a safer alternative for individuals who’ve recently undergone surgery or aren’t candidates for traditional surgery due to health concerns or tumor location.
SRS reduces the risk of infection and complications, ensuring a smoother recovery. It also effectively treats arteriovenous malformations and certain neurological disorders, such as trigeminal neuralgia.
Compared to conventional radiotherapy, SRS has fewer and milder side effects, resulting in enhanced treatment tolerance and a better quality of life. This treatment approach prioritizes patient well-being, offering a more precise and compassionate approach to healing.
Who it’s for
Deep within the intricate landscape of the brain, where delicate structures and essential functions intersect, lie many conditions requiring precise and targeted treatment.
Stereotactic radiosurgery (SRS) is a non-invasive treatment option for small brain tumors, both benign and malignant.
This treatment may be recommended for individuals with:
- Small brain tumors that are difficult to reach surgically or are located near critical structures pose a challenge for traditional surgical methods.
- Arteriovenous malformations (AVMs) or other functional abnormalities that can be effectively treated with precise radiation.
- Underlying health conditions that make conventional surgery a high-risk proposition, such as advanced age or comorbidities.
- Recent surgery makes the individual more susceptible to infection and complications and requires a lower-risk treatment alternative.
As a candidate for SRS, individuals can benefit from this innovative approach that minimizes damage to surrounding healthy tissues.
A treatment team will work closely with the individual to determine if SRS is best for their specific condition, providing a personalized and effective treatment plan.
Risks
In the field of stereotactic radiosurgery, it is essential to balance advantages and disadvantages. Evaluating the benefits of this non-invasive therapy requires careful consideration of potential side effects. Although it offers targeted precision, radiation may still lead to discomfort. Treatment teams help outline possible outcomes, emphasizing the need for patients to be aware of the associated risks.
Common side effects may include temporary fatigue, skin irritation, and potential hair loss in the treated area. These symptoms are generally milder than those associated with traditional radiotherapy. However, some patients may experience localized swelling in the brain near the treatment site, leading to headaches and nausea. In such cases, corticosteroids might be prescribed to manage the swelling.
Uncommon late effects may involve neurological issues, including memory loss or concentration difficulties, which may emerge months after treatment. Tumor recurrence in other brain regions may also occur, necessitating additional therapies. Awareness of these risks facilitates a better understanding of the intricacies of stereotactic radiosurgery and supports informed decision-making regarding patient care.
How you prepare
Preparing for Stereotactic Radiosurgery
Preparation is key to a smooth and successful stereotactic radiosurgery procedure. The following steps are necessary:
- Fasting after midnight: Refraining from eating or drinking after midnight before the procedure helps guarantee ideal conditions for treatment.
- Imaging tests: CT or MRI scans are used to locate the tumor and accurately inform the treatment plan.
- Comfortable clothing: On the day of the procedure, it is recommended that you wear loose-fitting clothing and avoid jewelry, makeup, and accessories.
- Companionship after the procedure: Have a friend or family member accompany you home after the procedure, as you may experience fatigue or sedation effects.
A thorough medical consultation is also necessary to review regular medications, allergies, and any implanted medical devices; this helps avoid complications during treatment.
What you can expect
Undergoing stereotactic radiosurgery can be a mysterious and intimidating experience, but knowing what to expect can ease anxiety and prepare you for the journey ahead. This outpatient procedure is guided by a multidisciplinary treatment team dedicated to precise targeting and ideal radiation dosage. A thorough treatment plan, developed over two weeks guarantees that every detail is meticulously considered.
During the procedure, a lightweight headframe or soft plastic mask may be worn to maintain stillness. If needed, numbing shots may be administered to ensure comfort. The treatment lasts 30 to 60 minutes, and the entire process, including preparation and observation, spans several hours.
Temporary side effects may arise, such as fatigue, skin irritation, and potential hair loss in the treated area. However, these are generally milder compared to conventional radiation therapy. Following the procedure, monitoring for immediate side effects will occur, and hydration recommendations will be provided.
Scheduled follow-up appointments will assess the treatment’s effectiveness and manage any late-onset symptoms.
Results
The outcome of stereotactic radiosurgery (SRS) becomes apparent after the procedure. As the body heals, the treatment starts to take effect.
SRS results are multifaceted and unfold over time. Potential outcomes include:
- Benign tumors shrink: Noticeable reductions in the size of benign tumors can be expected within 18 months to 2 years post-treatment.
- Malignant tumors respond quickly: Depending on the tumor type and individual factors, signs of shrinkage in malignant tumors may be seen within a few months.
- AVMs close off: Arteriovenous malformations typically begin to thicken and close off for 2 years following SRS treatment.
- Symptom relief: After undergoing SRS, patients may feel relief from symptoms of trigeminal neuralgia within weeks to several months.
Imaging studies like MRI will monitor treatment effectiveness and reveal significant changes in the radiated area over one to three years.
The treatment’s progress can be confirmed through these studies, which demonstrate the effectiveness of SRS.